Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.
Clinical trial NCT02877355 · COMPLETED
Trial details
- NCT number
- NCT02877355
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-22
- Primary completion
- 2017-11-24
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.